News & Research

PSMA PET finds more cancer than Axumin

  A PSMA PET scan (Ga-68-PSMA-11) detected more sites of cancer than an Axumin PET scan in the same recurrent patients. This prospective clinical trial was  conducted among 50 men at UCLA in 2018. All men had post-prostatectomy PSA from 0.2- 2.0 ng/ml.  The Calais et al. findings are summarized in the following table: Ga-68-PSMA-11 Axumin Detected - % of patients 56%...Read More

Tomato sauce vs. prostate cancer

  “Occasionally,… positive things happen in the field of cancer prevention science to popular, good-tasting foods.” Yes, broccoli family vegetables are wonderful, but may be “a hard food for the public to swallow.” By contrast, who doesn’t like tomatoes? But, studies using high-dose supplements of lycopene, the antioxidant red pigment in tomatoes thought to be the active anticancer ingredient, failed...Read More

Hospital Admissions for Prostate Biopsy Infections on the Rise

  Infection rates following prostate biopsy have remained stable since 2007, but visits to emergency departments and hospital and intensive care unit (ICU) admissions for post-biopsy infections continue to increase, according to a new study. Use of targeted prophylaxis remains limited. Investigators led by Jim C. Hu, MD, of New York Presbyterian Hospital, Weill Cornell Medical College, New York, used...Read More

Home urine test could ‘revolutionize diagnosis’

  A new pilot study concludes that at-home urine tests could make prostate cancer diagnoses shorter, simpler, and possibly even more accurate. Prostate cancer is common, affecting nearly half of males over 50. However, it tends to develop slowly, and in many cases, health professionals do not consider it clinically significant. In other words, it is not likely to shorten...Read More